Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy Subjects

The investigators aim to test the hypothesis that Laser speckle contrast imaging allows for the measurement of cutaneous blood flow following various durations of tourniquet ischemia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Microcirculation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University hospital

Angers, France

About this study

Ischemia and post occlusive reactive hyperemia in the skin is tested in healthy normal subjects for tourniquet ischemias of 1, 2 & 3 minutes at rest.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy volunteers
Affiliation to the French health system

Exclusion criteria

Any disease or chronic treatment

Treatment and study plan

tourniquet ischemia

Other

Recording of cutaneous blood flow on the forearm at rest before and following tourniquet ischemias of 1 , 2 & 3 minutes

Other names: Laser doppler flowmetry, Transcutaneous oxygen pressure, Near infra-red spectrometry, Plethysmography

Primary outcomes

Laser speckle

Time frame: with 2 minutes of ischemia

Peak value of laser speckle signal

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Registry information

Official study title

Evaluation Chez Des Sujets Volontaires Sains de l'ischémie-reperfusion cutanée

Acronym: SpeckleShake

Important dates

Study start: 2011
Primary completion: 2012
Study completion: 2012
First posted: Jul 26, 2010
Registry last updated: Nov 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed